This commentary suggests, if we truly care about inclusion of diverse patient populations in oncology clinical trials, we build and invest in trial infrastructure where patients already receive care, rather than setting overly burdensome and unrealistic expectations that patients travel to large academic centers. | Osarogiagbon, JAMA Netw Open 2026
